(813) 971-8080

7210 Wareham Drive, Tampa, FL 33647

Author name: John LaRosa

Employers and Insurers Push Back on GLP-1 Drugs Coverage

June 13, 2024 Just 33% of employers and health plans cover the drugs for obesity, according to a report published Tuesday by consultant firm Pharmaceutical Strategies Group. The biggest reason? The drugs’ high costs. “Affordability is the main challenge, and we have seen a few employers offer coverage, then pull back after they evaluated the […]

Employers and Insurers Push Back on GLP-1 Drugs Coverage Read More »

Kroger’s Little Clinics Adds GLP-1 Drugs To Its Weight Loss Program

June 11, 2024 Kroger Health’s The Little Clinic LLC is announcing a renewed approach to its weight management program, offering a holistic and personalized approach to professional medical support and education. When medically appropriate, patients will be able to explore medical treatment, including GLP-1s such as Wegovy, Zepabound and others as part of their weight

Kroger’s Little Clinics Adds GLP-1 Drugs To Its Weight Loss Program Read More »

Medifast To Launch National Marketing Campaign

May 20, 2024 Medifast today announced the launch of the first phase of its multimillion-dollar national marketing campaign. The campaign will highlight OPTAVIA’s new offering in collaboration with LifeMD®, the GLP-1 Lifestyle Program. View the full release here: https://www.businesswire.com/news/home/20240520770526/en/ This will be an investment of up to $30 million in company-led marketing efforts. Medifast is committed

Medifast To Launch National Marketing Campaign Read More »

How GLP-1 Drugs Are Changing The Weight Loss Market – Podcast

May 9, 2024 John LaRosa, Marketdata’s Research Director and founder, was recently interviewed by Kimberly Adams at Marketplace, a business and economic program, along with several others, about how the weight loss market is changing currently, being affected by the hugely popular GLP-1 weight loss medications. Here’s the interview, on audio. Click this link to

How GLP-1 Drugs Are Changing The Weight Loss Market – Podcast Read More »

Medifast Reports Q1 2024 Results

April 29, 2024 Management said that: “Our new model is highly differentiated from competitors, with a holistic approach including our habit-based and Coach guided solution along with nutrition products and community support. It will be supported by a reimagined framework for customer acquisition, with a new company-led national marketing campaign, enhancing both awareness of the

Medifast Reports Q1 2024 Results Read More »

Higher Quality Weight Loss Drugs Coming in the Future

April 29, 2024 According to an article at Biospace.com, GLP-1 agonists are set to become the best-selling drugs in 2024, but the biopharma industry isn’t resting on its collective laurels. Instead, some companies are pushing to improve upon the popular obesity medicines with therapies that promote higher-quality weight loss. Clinical studies have shown that up

Higher Quality Weight Loss Drugs Coming in the Future Read More »

Telehealth Weight Loss Market Worth $6.9 Billion And Growing

April 13, 2024 Marketdata LLC (parent company of DietBusinessWatch) has just released new research, a report entitled: “The Telehealth Weight Loss Market”. The market for weight loss programs delivered via telehealth / telemedicine companies is worth $6.9 billion, and growing. Telehealth soared during the pandemic in 2020 as consumers stayed home and communicated with their

Telehealth Weight Loss Market Worth $6.9 Billion And Growing Read More »

Scroll to Top